{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:44:06Z","timestamp":1774442646095,"version":"3.50.1"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T00:00:00Z","timestamp":1708300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019779","name":"Qatar National Library","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.clineuro.2024.108183","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T02:27:53Z","timestamp":1708396073000},"page":"108183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Guillain-Barr\u00e9 syndrome after COVID-19 vaccination: A systematic review and analysis of case reports"],"prefix":"10.1016","volume":"238","author":[{"given":"Mohammad T.","family":"Abuawwad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad J.J.","family":"Taha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad J.","family":"Taha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmeena Abdelall","family":"Kozaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Obaida","family":"Falah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim T.","family":"Abuawwad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsayed Mohamed","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman A.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Aladawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hashem Abu","family":"Serhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clineuro.2024.108183_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"issue":"2","key":"10.1016\/j.clineuro.2024.108183_bib2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000184748","article-title":"The Epidemiology of Guillain-Barr\u00e9 Syndrome Worldwide","volume":"32","author":"McGrogan","year":"2009","journal-title":"Neuroepidemiology"},{"issue":"22","key":"10.1016\/j.clineuro.2024.108183_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214222","article-title":"Triggers of Guillain-Barr\u00e9 Syndrome: Campylobacter jejuni Predominates","volume":"23","author":"Finsterer","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.clineuro.2024.108183_bib4","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/cid\/ciu005","article-title":"Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence","volume":"58","author":"Vellozzi","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.clineuro.2024.108183_bib5","doi-asserted-by":"crossref","unstructured":"H. Fujimura, Chapter 21 - The Guillain\u2013Barr\u00e9 syndrome, Handbook of Clinical Neurology, 115, Elsevier,, 2013, pp. 383\u2013402G. Said, C. Krarup.","DOI":"10.1016\/B978-0-444-52902-2.00021-7"},{"issue":"12","key":"10.1016\/j.clineuro.2024.108183_bib6","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1002\/acn3.50946","article-title":"Antecedent infections in Guillain-Barr\u00e9 syndrome: a single-center, prospective study","volume":"6","author":"Hao","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"10280","key":"10.1016\/j.clineuro.2024.108183_bib7","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr; syndrome","volume":"397","author":"Shahrizaila","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.clineuro.2024.108183_bib8","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/jnnp-2019-322479","article-title":"Ultrastructural mechanisms of macrophage-induced demyelination in Guillain-Barr\u00e9 syndrome","volume":"91","author":"Koike","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"Pt 3","key":"10.1016\/j.clineuro.2024.108183_bib9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/118.3.577","article-title":"Guillain-Barr\u00e9 syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases","volume":"118","author":"Griffin","year":"1995","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108183_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1017\/cjn.2021.102","article-title":"Guillain Barre Syndrome as a Complication of COVID-19: A Systematic Review","volume":"49","author":"Aladawi","year":"2022","journal-title":"Can. J. Neurol. Sci."},{"issue":"7","key":"10.1016\/j.clineuro.2024.108183_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.clineuro.2024.108183_bib12","unstructured":"NIH. Study Quality Assessment Tools | NHLBI, NIH."},{"issue":"Pt 1","key":"10.1016\/j.clineuro.2024.108183_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria.","volume":"137","author":"Fokke","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2024.108183_bib14","unstructured":"Modified Erasmus GBS Outcome Score (EGOS) at day 7 of admission."},{"issue":"3","key":"10.1016\/j.clineuro.2024.108183_bib15","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s10072-021-05776-0","article-title":"Miller Fisher syndrome following Pfizer COVID-19 vaccine","volume":"43","author":"Abicic","year":"2022","journal-title":"Neurol. Sci."},{"issue":"4","key":"10.1016\/j.clineuro.2024.108183_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2021.07.838","article-title":"Guillain-Barr\u00c9 Syndrome, or Acute on Chronic Inflammatory Demyelinating Polyneuropathy, Following Moderna Covid-19 Vaccine","volume":"160","author":"Abo-Zed","year":"2021","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108183_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.5237","article-title":"Could Guillain-Barre syndrome be triggered by COVID-19 vaccination?","volume":"10","author":"Aldeeb","year":"2022","journal-title":"Clin. Case Rep."},{"issue":"1","key":"10.1016\/j.clineuro.2024.108183_bib18","first-page":"2","article-title":"Guillain-Barre Syndrome Two Weeks after 1st Dose of Covid-19 Vaccine","volume":"4","author":"Alekseyev","year":"2022","journal-title":"J. Phys. Med. Rehabil. Stud. Rep. SRC\/JPMRS\/166"},{"key":"10.1016\/j.clineuro.2024.108183_bib19","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.121721.1","article-title":"Neuro-immunological complications post COVID-19 vaccination: two case reports","volume":"11","author":"Aljamea","year":"2022","journal-title":"F1000Research"},{"key":"10.1016\/j.clineuro.2024.108183_bib20","article-title":"Combined peripheral and central nervous system demyelination post-COVID-19 vaccination: A case report","volume":"2","author":"AlKolfat","year":"2022","journal-title":"Neuroimmunol. Rep."},{"issue":"2","key":"10.1016\/j.clineuro.2024.108183_bib21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ana.26144","article-title":"Guillain-Barre Syndrome Variant Occurring after SARS-CoV-2 Vaccination","volume":"90","author":"Allen","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clineuro.2024.108183_bib22","article-title":"Guillain-Barre syndrome following COVID-19 vaccination: a case report and an updated review","volume":"2","author":"Aly","year":"2022","journal-title":"Neuroimmunol. Rep."},{"issue":"7","key":"10.1016\/j.clineuro.2024.108183_bib23","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1007\/s10072-022-05982-4","article-title":"Bilateral facial palsy after COVID-19 vaccination","volume":"43","author":"Andreozzi","year":"2022","journal-title":"Neurol. Sci."},{"issue":"4","key":"10.1016\/j.clineuro.2024.108183_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.5733","article-title":"Guillain-Barre syndrome after mRNA-1273 (Moderna) COVID-19 vaccination: A case report","volume":"10","author":"Anjum","year":"2022","journal-title":"Clin. Case Rep."},{"issue":"4","key":"10.1016\/j.clineuro.2024.108183_bib25","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.neurop.2021.09.002","article-title":"Guillain-Barre syndrome after vaccination for Covid-19. The first report in Latin America","volume":"1","author":"Arce G\u00e1lvez","year":"2021","journal-title":"Neurol. Perspect."},{"issue":"8","key":"10.1016\/j.clineuro.2024.108183_bib26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.12691\/ajmcr-9-8-10","article-title":"Guillain-Barr\u00e9 Syndrome in a 67-year-old Male Post COVID-19 Vaccination (Astra Zeneca)","volume":"9","author":"Azam","year":"2021","journal-title":"Am. J. Med. Case Rep."},{"issue":"5","key":"10.1016\/j.clineuro.2024.108183_bib27","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s13760-021-01798-9","article-title":"Guillain-Barre syndrome following Covid-19 immunization: a report of two cases","volume":"122","author":"Bax","year":"2022","journal-title":"Acta Neurol. Belg."},{"issue":"2","key":"10.1016\/j.clineuro.2024.108183_bib28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.5606\/tftrd.2022.9984","article-title":"A case of Guillain-Barre syndrome after the second dose of AstraZeneca COVID-19 vaccination","volume":"68","author":"Bazrafshan","year":"2022","journal-title":"Turk. J. Phys. Med Rehabil."},{"key":"10.1016\/j.clineuro.2024.108183_bib29","doi-asserted-by":"crossref","unstructured":"W. Bello Marq, A. AguirreIII. Guillain-Barr\u00e9 Syndrome Post-COVID 19 Vaccination with Sinovac CoronaVac in a 59-Year-Old Male: First Reported Case in the Philippines 6 ( 8 J. Infect. Dis. Epidemiol.2022.","DOI":"10.23937\/2474-3658\/1510265"},{"key":"10.1016\/j.clineuro.2024.108183_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.894872","article-title":"Case Report: Post-COVID-19 Vaccine Recurrence of Guillain\u2013Barr\u00e9 Syndrome Following an Antecedent Parainfectious COVID-19\u2013Related GBS","volume":"13","author":"Bellucci","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clineuro.2024.108183_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.119883","article-title":"Guillain-Barr\u00e9 syndrome post COVID-19 vaccine: Two cases report study","volume":"429","author":"Benlamkadam","year":"2021","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.clineuro.2024.108183_bib32","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4103\/ijph.ijph_1716_21","article-title":"Post coronavirus disease-2019 vaccination Guillain-Barre syndrome","volume":"65","author":"Biswas","year":"2021","journal-title":"Indian J. Public Health"},{"issue":"3","key":"10.1016\/j.clineuro.2024.108183_bib33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/jnnp-2021-327027","article-title":"Bilateral facial weakness with paraesthesia variant of Guillain-Barre syndrome following Vaxzevria COVID-19 vaccine","volume":"93","author":"Bonifacio","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.clineuro.2024.108183_bib34","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s10072-021-05733-x","article-title":"Guillain-Barre syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases","volume":"43","author":"Bouattour","year":"2022","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.clineuro.2024.108183_bib35","doi-asserted-by":"crossref","unstructured":"O. Carranza, D. Babici, S. Waheed, F. YousufNeurologic Sequela of COVID-19: Guillain-Barre Syndrome Following Johnson & Johnson COVID-19 Vaccination 4 14 Cureus, e24252.2022.","DOI":"10.7759\/cureus.24252"},{"issue":"7","key":"10.1016\/j.clineuro.2024.108183_bib36","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.nmd.2022.05.003","article-title":"Bilateral facial palsy with paresthesias, variant of Guillain-Barre syndrome following COVID-19 vaccine: A case series of 9 patients","volume":"32","author":"Castiglione","year":"2022","journal-title":"Neuromuscul. Disord."},{"issue":"3","key":"10.1016\/j.clineuro.2024.108183_bib37","first-page":"183","article-title":"Guillan-Barre Syndrome after First Vaccination Dose against COVID-19: Case Report","volume":"64","author":"Censcak","year":"2021","journal-title":"Acta Med. (Hrad-.-. Kral. )"},{"issue":"2","key":"10.1016\/j.clineuro.2024.108183_bib38","doi-asserted-by":"crossref","first-page":"497","DOI":"10.54029\/2022ywu","article-title":"Guillain\u2013Barr\u00e9 syndrome with weakness confined to the bilateral upper extremities after ChAdOx1-S\/ nCoV-19 vaccination","volume":"27","author":"Chang","year":"2022","journal-title":"Neurol. Asia"},{"issue":"11","key":"10.1016\/j.clineuro.2024.108183_bib39","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2022-251361","article-title":"Miller Fisher syndrome after Pfizer BioNTech vaccine booster responsive to intravenous Ig treatment","volume":"15","author":"Chen","year":"2022","journal-title":"BMJ Case Rep."},{"issue":"2","key":"10.1016\/j.clineuro.2024.108183_bib40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1474-4422(21)00416-6","article-title":"Guillain-Barr\u00e9 syndrome after vaccination against COVID-19","volume":"21","author":"Chun","year":"2022","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.clineuro.2024.108183_bib41","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/cen3.12678","article-title":"Guillain-Barre syndrome after coronavirus disease 2019 vaccine: A temporal association","volume":"13","author":"da Silva","year":"2022","journal-title":"Clin. Exp. Neuroimmunol."},{"issue":"9","key":"10.1016\/j.clineuro.2024.108183_bib42","article-title":"Axonal-Variant Guillian-Barre Syndrome Temporally Associated With mRNA-Based Moderna SARS-CoV-2 Vaccine","volume":"13","author":"Dalwadi","year":"2021","journal-title":"Cureus"},{"issue":"11","key":"10.1016\/j.clineuro.2024.108183_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-246701","article-title":"Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination","volume":"14","author":"Dang","year":"2021","journal-title":"BMJ Case Rep."},{"issue":"4","key":"10.1016\/j.clineuro.2024.108183_bib44","doi-asserted-by":"crossref","first-page":"01","DOI":"10.56558\/journal.ejmscr.1001041","article-title":"The First Ethiopian Case Report of Post-COVID-19 Vaccine Associated Guillain-Barre Syndrome","volume":"2","author":"Demissie","year":"2022","journal-title":"Enormous J. Med. Sci. Curr. Res."},{"issue":"1","key":"10.1016\/j.clineuro.2024.108183_bib45","article-title":"Variant Guillain\u2013Barre Syndrome Following SARS-CoV-2 Vaccination: Case Report and Review of the Literature","volume":"3","author":"Donaldson","year":"2022","journal-title":"Can. J. Neurol. Sci. \/ J. Can. Des. Sci. Neurol."},{"issue":"10","key":"10.1016\/j.clineuro.2024.108183_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.6451","article-title":"Guillain-Barre syndrome following COVID-19 vaccine: A case report","volume":"10","author":"Fakhari","year":"2022","journal-title":"Clin. Case Rep."},{"key":"10.1016\/j.clineuro.2024.108183_bib47","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.21919","article-title":"Neurological Conditions Following COVID-19 Vaccinations: Chance or Association?","author":"Fernandes","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.clineuro.2024.108183_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2021.e01226","article-title":"Guillain-Barre syndrome 15 days after COVID-19 despite SARS-CoV-2 vaccination","volume":"25","author":"Finsterer","year":"2021","journal-title":"IDCases"},{"key":"10.1016\/j.clineuro.2024.108183_bib49","article-title":"Exacerbating Guillain-Barre Syndrome Eight Days after Vector-Based COVID-19 Vaccination","volume":"2021","author":"Finsterer","year":"2021","journal-title":"Case Rep. Infect. Dis."},{"issue":"1","key":"10.1016\/j.clineuro.2024.108183_bib50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/qjmed\/hcab296","article-title":"A case of sensory ataxic Guillain-Barre syndrome with immunoglobulin G anti-GM1 antibodies following the first dose of mRNA COVID-19 vaccine BNT162b2 (Pfizer)","volume":"115","author":"Fukushima","year":"2022","journal-title":"QJM"},{"key":"10.1016\/j.clineuro.2024.108183_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120330","article-title":"COVID-19 vaccine-related Guillain-Barre syndrome in the Liguria region of Italy: A multicenter case series","volume":"440","author":"Germano","year":"2022","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.clineuro.2024.108183_bib52","article-title":"Guillain-Barr\u00e9 Syndrome: A Case Report of Post Covid-19 Vaccination in the Philippines","volume":"5","author":"Gonzales","year":"2022","journal-title":"J. Health Med. Sci."},{"issue":"4","key":"10.1016\/j.clineuro.2024.108183_bib53","doi-asserted-by":"crossref","first-page":"777","DOI":"10.9758\/cpn.2022.20.4.777","article-title":"Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination: A Case Report","volume":"20","author":"Gunawan","year":"2022","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"6","key":"10.1016\/j.clineuro.2024.108183_bib54","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-243629","article-title":"Case of Guillain-Barre syndrome following COVID-19 vaccine","volume":"14","author":"Hasan","year":"2021","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.clineuro.2024.108183_bib55","doi-asserted-by":"crossref","first-page":"454","DOI":"10.9734\/jpri\/2021\/v33i59B34403","article-title":"A Case Report on Post COVID -19 Vaccine Associated Guillain\u2013Barr\u00e9 Syndrome","author":"Hemalatha","year":"2021","journal-title":"J. Pharm. Res. Int."},{"key":"10.1016\/j.clineuro.2024.108183_bib56","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.936896","article-title":"A Clinical Case of COVID-19 Vaccine-Associated Guillain-Barre Syndrome","volume":"23","author":"Hilts","year":"2022","journal-title":"Am. J. Case Rep."},{"issue":"19","key":"10.1016\/j.clineuro.2024.108183_bib57","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.2169\/internalmedicine.9781-22","article-title":"Loss of Taste as an Initial Symptom of a \"Facial Diplegia and Paresthesia\" Variant of Guillain-Barre Syndrome","volume":"61","author":"Hiraga","year":"2022","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108183_bib58","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/lt.26279","article-title":"Guillain-Barre Syndrome After COVID-19 mRNA Vaccination in a Liver Transplantation Recipient With Favorable Treatment Response","volume":"28","author":"Hughes","year":"2022","journal-title":"Liver Transpl."},{"issue":"8","key":"10.1016\/j.clineuro.2024.108183_bib59","article-title":"Guillain-Barre Syndrome: A Sequela of the Original COVID-19 Infection or Vaccination","volume":"14","author":"Ilyas","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.clineuro.2024.108183_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2021.106887","article-title":"Guillain-Barre syndrome after AstraZeneca COVID-19-vaccination: A causal or casual association?","volume":"208","author":"Introna","year":"2021","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"7","key":"10.1016\/j.clineuro.2024.108183_bib61","article-title":"Facial Diplegia: A Rare, Atypical Variant of Guillain-Barre Syndrome and Ad26.COV2.S Vaccine","volume":"13","author":"Jain","year":"2021","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.clineuro.2024.108183_bib62","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4103\/aian.aian_292_21","article-title":"Post COVID-19 Vaccination GBS-Association or Causation?","volume":"25","author":"Jain","year":"2022","journal-title":"Ann. Indian Acad. Neurol."},{"issue":"10","key":"10.1016\/j.clineuro.2024.108183_bib63","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-244527","article-title":"Guillain-Barre syndrome presenting with facial diplegia following COVID-19 vaccination in two patients","volume":"14","author":"Kanabar","year":"2021","journal-title":"BMJ Case Rep."},{"issue":"5","key":"10.1016\/j.clineuro.2024.108183_bib64","doi-asserted-by":"crossref","first-page":"703","DOI":"10.32598\/bcn.2021.3565.1","article-title":"Guillain-Barre Syndrome and COVID-19 Vaccine: A Report of Nine Patients","volume":"12","author":"Karimi","year":"2021","journal-title":"Basic Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.clineuro.2024.108183_bib65","doi-asserted-by":"crossref","first-page":"852","DOI":"10.33314\/jnhrc.v19i04.3803","article-title":"Post COVID-19 vaccine Guillain-Barre syndrome","volume":"19","author":"Khadka","year":"2022","journal-title":"J. Nepal Health Res Counc."},{"issue":"2","key":"10.1016\/j.clineuro.2024.108183_bib66","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3126\/jonmc.v10i2.41790","article-title":"Guillain-Barre Syndrome Following Ad26. Cov2. S Covid-19 Vaccine: A Case Report","volume":"10","author":"Khanal","year":"2021","journal-title":"J. Nobel Med. Coll."},{"key":"10.1016\/j.clineuro.2024.108183_bib67","article-title":"Guillain-Barre Syndrome and Variants Following COVID-19 Vaccination: Report of 13 Cases","volume":"12","author":"Kim","year":"2021","journal-title":"Front Neurol."},{"issue":"7","key":"10.1016\/j.clineuro.2024.108183_bib68","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2022.37.e58","article-title":"Guillain-Barre Syndrome After Two COVID-19 Vaccinations: Two Case Reports With Follow-up Electrodiagnostic Study","volume":"37","author":"Kim","year":"2022","journal-title":"J. Korean Med Sci."},{"issue":"3","key":"10.1016\/j.clineuro.2024.108183_bib69","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s10072-021-05849-0","article-title":"Guillain-Barre syndrome associated with BNT162b2 COVID vaccination: a first case report from South Korea","volume":"43","author":"Kim","year":"2022","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.clineuro.2024.108183_bib70","article-title":"A Pediatric Case of Sensory Predominant Guillain-Barre Syndrome Following COVID-19 Vaccination","volume":"9","author":"Kim","year":"2022","journal-title":"Child Neurol. Open"},{"key":"10.1016\/j.clineuro.2024.108183_bib71","article-title":"The Development of Guillain Barre Syndrome Subsequent to Administration of Ad26.COV2.S Vaccine","volume":"1-3","author":"Koreen","year":"2021","journal-title":"J. Neurol. Res. Rev. Rep."},{"issue":"9","key":"10.1016\/j.clineuro.2024.108183_bib72","article-title":"A Rare Case of Guillain-Barre Syndrome following COVID-19 Vaccination","volume":"8","author":"Kripalani","year":"2021","journal-title":"Eur. J. Case Rep. Intern Med"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108183_bib73","article-title":"Polyneuritis Cranialis Associated with BNT162b2 mRNA COVID-19 Vaccine in a Healthy Adolescent","volume":"10","author":"Kulsirichawaroj","year":"2022","journal-title":"Vaccin. (Basel)"},{"issue":"2","key":"10.1016\/j.clineuro.2024.108183_bib74","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/19418744211065242","article-title":"Guillain-Barre Syndrome with Rapid Onset and Autonomic Dysfunction Following First Dose of Pfizer-BioNTech COVID-19 Vaccine: A Case Report","volume":"12","author":"Lanman","year":"2022","journal-title":"Neurohospitalist"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108183_bib75","first-page":"7","article-title":"Guillain-Barr\u00e9 Syndrome Following the ChAdOx1-S\/nCoV-19 Vaccine: A Case Report","volume":"24","author":"Lee","year":"2022","journal-title":"J. Korean Assoc. EMG-Electrodiagn. Med."},{"issue":"3","key":"10.1016\/j.clineuro.2024.108183_bib76","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s13760-022-01941-0","article-title":"Neuromuscular complications after COVID-19 vaccination: a series of eight patients","volume":"122","author":"Leemans","year":"2022","journal-title":"Acta Neurol. Belg."},{"issue":"6","key":"10.1016\/j.clineuro.2024.108183_bib77","doi-asserted-by":"crossref","first-page":"2125753","DOI":"10.1080\/21645515.2022.2125753","article-title":"Miller-Fisher syndrome and Guillain\u2013Barre syndrome overlap syndrome following inactivated COVID-19 vaccine: Case report and scope review","volume":"18","author":"Liang","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"issue":"46","key":"10.1016\/j.clineuro.2024.108183_bib78","doi-asserted-by":"crossref","first-page":"E1766","DOI":"10.1503\/cmaj.210947","article-title":"Guillain-Barre syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain-Barre syndrome","volume":"193","author":"Ling","year":"2021","journal-title":"CMAJ"},{"key":"10.1016\/j.clineuro.2024.108183_bib79","article-title":"Guillain-Barre syndrome following coronavirus disease vaccine: First report from Nepal","volume":"10","author":"Luitel","year":"2022","journal-title":"SAGE Open Med Case Rep."},{"key":"10.1016\/j.clineuro.2024.108183_bib80","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pediatrneurol.2021.10.003","article-title":"Guillain-Barre Syndrome After COVID-19 Vaccination in an Adolescent","volume":"126","author":"Malamud","year":"2022","journal-title":"Pedia Neurol."},{"issue":"2","key":"10.1016\/j.clineuro.2024.108183_bib81","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/ana.26143","article-title":"Guillain-Barre Syndrome following ChAdOx1-S\/nCoV-19 Vaccine","volume":"90","author":"Maramattom","year":"2021","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.clineuro.2024.108183_bib82","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s13760-021-01838-4","article-title":"Guillain-Barre syndrome following COVID-19 vaccine mRNA-1273: a case report","volume":"122","author":"Masuccio","year":"2022","journal-title":"Acta Neurol. Belg."},{"issue":"9","key":"10.1016\/j.clineuro.2024.108183_bib83","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.4756","article-title":"COVID-19 vaccine causing Guillain-Barre syndrome, a rare potential side effect","volume":"9","author":"Matarneh","year":"2021","journal-title":"Clin. Case Rep."},{"issue":"7","key":"10.1016\/j.clineuro.2024.108183_bib84","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-244125","article-title":"Guillain-Barre syndrome after COVID-19 vaccination","volume":"14","author":"McKean","year":"2021","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.clineuro.2024.108183_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577691","article-title":"Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature","volume":"359","author":"Min","year":"2021","journal-title":"J. Neuroimmunol."},{"issue":"9","key":"10.1016\/j.clineuro.2024.108183_bib86","article-title":"A Rare Variant of Guillain-Barre Syndrome Following Ad26.COV2.S Vaccination","volume":"13","author":"Morehouse","year":"2021","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108183_bib87","doi-asserted-by":"crossref","DOI":"10.2174\/1874205X-v16-e2207270","article-title":"Guillain-Barr\u00e9 Syndrome with Lethal Outcome Following COVID-19 Vaccination - Case Report Supported by Autopsy Examination","volume":"16","author":"Mosna","year":"2022","journal-title":"Open Neurol. J."},{"issue":"6","key":"10.1016\/j.clineuro.2024.108183_bib88","article-title":"Guillain-Barr\u00e9 Syndrome After Receiving the First Dose of Oxford\u2013AstraZeneca SARS-CoV-2 Vaccine","volume":"60","author":"Mozhdehipanah","year":"2022","journal-title":"Acta Med. Iran."},{"issue":"1","key":"10.1016\/j.clineuro.2024.108183_bib89","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s42399-022-01124-1","article-title":"Sub-acute Onset of Guillain-Barre Syndrome Post-mRNA-1273 Vaccination: a Case Report","volume":"4","author":"Nagalli","year":"2022","journal-title":"SN Compr. Clin. Med"},{"key":"10.1016\/j.clineuro.2024.108183_bib90","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.30888","article-title":"COVID-19 Vaccination a Cause of Guillain-Barr\u00e9 Syndrome? A Case Series","author":"Nagdev","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108183_bib91","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12883-022-02838-4","article-title":"A case of Miller Fisher syndrome with delayed onset peripheral facial nerve palsy after COVID-19 vaccination: a case report","volume":"22","author":"Nanatsue","year":"2022","journal-title":"BMC Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2024.108183_bib92","article-title":"Guillain-Barre Syndrome Post COVID-19 Vaccination: Case Report","volume":"7","author":"Nasiri","year":"2022","journal-title":"Int. J. Infect. Dis. Ther."},{"issue":"11","key":"10.1016\/j.clineuro.2024.108183_bib93","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.1007\/s10072-021-05467-w","article-title":"A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine","volume":"42","author":"Nasuelli","year":"2021","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.clineuro.2024.108183_bib94","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/s12883-021-02489-x","article-title":"Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination","volume":"21","author":"Nishiguchi","year":"2021","journal-title":"BMC Neurol."},{"issue":"11","key":"10.1016\/j.clineuro.2024.108183_bib95","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2169\/internalmedicine.8967-21","article-title":"Sensory Ataxic Guillain-Barre Syndrome with Dysgeusia after mRNA COVID-19 Vaccination","volume":"61","author":"Ogata","year":"2022","journal-title":"Intern Med"},{"key":"10.1016\/j.clineuro.2024.108183_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2021.e01143","article-title":"Guillain-Barre syndrome following the first dose of SARS-CoV-2 vaccine: A temporal occurrence, not a causal association","volume":"24","author":"Ogbebor","year":"2021","journal-title":"IDCases"},{"issue":"4","key":"10.1016\/j.clineuro.2024.108183_bib97","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-242956","article-title":"Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1","volume":"14","author":"Patel","year":"2021","journal-title":"BMJ Case Rep."},{"issue":"1","key":"10.1016\/j.clineuro.2024.108183_bib98","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1186\/s13256-022-03592-4","article-title":"Miller\u2013Fisher syndrome after first dose of Oxford\/AstraZeneca coronavirus disease 2019 vaccine: a case report","volume":"16","author":"Pirola","year":"2022","journal-title":"J. Med. Case Rep."},{"issue":"3","key":"10.1016\/j.clineuro.2024.108183_bib99","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1177\/19418744221097350","article-title":"Facial Diplegia as the Sole Manifestation of Post-Vaccination Guillain-Barre Syndrome: A Case Report and Literature Review","volume":"12","author":"Prado","year":"2022","journal-title":"Neurohospitalist"},{"issue":"3","key":"10.1016\/j.clineuro.2024.108183_bib100","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3390\/neurolint13030040","article-title":"A Novel Case of Bifacial Diplegia Variant of Guillain-Barre Syndrome Following Janssen COVID-19 Vaccination","volume":"13","author":"Prasad","year":"2021","journal-title":"Neurol. Int"},{"issue":"5","key":"10.1016\/j.clineuro.2024.108183_bib101","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1080\/20009666.2021.1954284","article-title":"A case of Guillain-Barre syndrome following Pfizer COVID-19 vaccine","volume":"11","author":"Rao","year":"2021","journal-title":"J. Community Hosp. Intern Med Perspect."},{"key":"10.1016\/j.clineuro.2024.108183_bib102","article-title":"Post-COVID-19 vaccine Guillain-Barre syndrome; first reported case from Qatar","volume":"67","author":"Razok","year":"2021","journal-title":"Ann. Med Surg. (Lond. )"},{"key":"10.1016\/j.clineuro.2024.108183_bib103","doi-asserted-by":"crossref","unstructured":"J. Richardson-May, E. Purcaru, C. Campbell, C. Hillier, B. ParkinGuillain-Barr\u00e9 Syndrome and Unilateral Optic Neuritis Following Vaccination for COVID-19: A Case Report and Literature Review Neuro-Ophthalmol.2022, , 1\u20137..","DOI":"10.1080\/01658107.2022.2048861"},{"key":"10.1016\/j.clineuro.2024.108183_bib104","doi-asserted-by":"crossref","unstructured":"Rohilla R., Kakkar A.K., Divyashree K., Mohindra R., Suri V. Recombinant protein subunit COVID-19 vaccine-induced Guillain-Barre Syndrome in an adolescent: A case report. Br J Clin Pharmacol. 2022.","DOI":"10.22541\/au.165477964.40882211\/v1"},{"issue":"6","key":"10.1016\/j.clineuro.2024.108183_bib105","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1016\/j.jemermed.2021.07.062","article-title":"Guillain-Barre Syndrome Presenting as Facial Diplegia after COVID-19 Vaccination: A Case Report","volume":"61","author":"Rossetti","year":"2021","journal-title":"J. Emerg. Med"},{"key":"10.1016\/j.clineuro.2024.108183_bib106","unstructured":"Saraswat B., Kumar S., Rawal D., Johri S., Rai P.K., Grover A. Acute Onset Quadriparesis Post COVID 19 Vaccination: A Case Report. 2021."},{"issue":"11","key":"10.1016\/j.clineuro.2024.108183_bib107","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1080\/21645515.2021.1954826","article-title":"Electromyoneurography and laboratory findings in a case of Guillain-Barre syndrome after second dose of Pfizer COVID-19 vaccine","volume":"17","author":"Scendoni","year":"2021","journal-title":"Hum. Vaccin Immunother."},{"issue":"20","key":"10.1016\/j.clineuro.2024.108183_bib108","article-title":"Miller Fisher syndrome after COVID-19 vaccination: Case report and review of literature","volume":"101","author":"Siddiqi","year":"2022","journal-title":"Med. (Baltim. )"},{"key":"10.1016\/j.clineuro.2024.108183_bib109","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.vacune.2022.05.004","article-title":"Case report of Guillain-Barr\u00e9 Syndrome after COVID BNT162b2 mRNA vaccine","volume":"23","author":"Sosa-Hern\u00e1ndez","year":"2022","journal-title":"Vacunas (Engl. Ed. )"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108183_bib110","first-page":"46","article-title":"The First Guillain-Barr? Syndrome After SARS-CoV-2 Vaccination in Taiwan","volume":"31","author":"Su","year":"2022","journal-title":"Acta Neurol. Taiwan"},{"issue":"5","key":"10.1016\/j.clineuro.2024.108183_bib111","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2045153","article-title":"Post COVID-19 vaccination Guillain-Barre syndrome: three cases","volume":"18","author":"Tabatabaee","year":"2022","journal-title":"Hum. Vaccin Immunother."},{"issue":"5","key":"10.1016\/j.clineuro.2024.108183_bib112","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/qjmed\/hcac102","article-title":"Guillain-Barre syndrome after BNT162b2 (Pfizer-BioNTec) vaccination","volume":"115","author":"Takahashi","year":"2022","journal-title":"QJM"},{"key":"10.1016\/j.clineuro.2024.108183_bib113","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.935275","article-title":"Guillain-Barre Syndrome After Ad26.COV2.S Vaccination","volume":"23","author":"Thant","year":"2022","journal-title":"Am. J. Case Rep."},{"issue":"11","key":"10.1016\/j.clineuro.2024.108183_bib114","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1007\/s10072-021-05523-5","article-title":"Guillain-Barre syndrome following BNT162b2 COVID-19 vaccine","volume":"42","author":"Trimboli","year":"2021","journal-title":"Neurol. Sci."},{"issue":"2","key":"10.1016\/j.clineuro.2024.108183_bib115","article-title":"Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine","volume":"13","author":"Waheed","year":"2021","journal-title":"Cureus"},{"issue":"7","key":"10.1016\/j.clineuro.2024.108183_bib116","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2169\/internalmedicine.8851-21","article-title":"Miller Fisher Syndrome Following Vaccination against SARS-CoV-2","volume":"61","author":"Yamakawa","year":"2022","journal-title":"Intern Med"},{"issue":"2","key":"10.1016\/j.clineuro.2024.108183_bib117","article-title":"Facial Diplegia Variant of Guillain-Barre Syndrome in Pregnancy Following COVID-19 Vaccination: A Case Report","volume":"14","author":"Zubair","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.clineuro.2024.108183_bib118","unstructured":"Mathieu E., Ritchie H., Rod\u00e9s-Guirao L., Appel C., Giattino C., Hasell J., et al. Coronavirus Pandemic (COVID-19). Our World in Data. 2020."},{"issue":"10","key":"10.1016\/j.clineuro.2024.108183_bib119","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1007\/s00415-016-8237-6","article-title":"Higher frequencies of HLA DQB1*05:01 and anti-glycosphingolipid antibodies in a cluster of severe Guillain\u2013Barr\u00e9 syndrome","volume":"263","author":"Schirmer","year":"2016","journal-title":"J. Neurol."},{"issue":"11","key":"10.1016\/j.clineuro.2024.108183_bib120","first-page":"1305","article-title":"[Epidemiology of Guillain-Barr\u00e9 Syndrome]","volume":"67","author":"Yoshikawa","year":"2015","journal-title":"Brain Nerve"},{"key":"10.1016\/j.clineuro.2024.108183_bib121","unstructured":"WHO. Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) COVID-19 subcommittee on reports of Guillain-Barr\u00e9 Syndrome (GBS) following adenovirus vector COVID-19 vaccines. 2021."},{"issue":"8","key":"10.1016\/j.clineuro.2024.108183_bib122","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.autrev.2008.06.009","article-title":"Is autoimmunity a matter of sex?","volume":"7","author":"Lleo","year":"2008","journal-title":"Autoimmun. Rev."},{"issue":"11","key":"10.1016\/j.clineuro.2024.108183_bib123","doi-asserted-by":"crossref","first-page":"6710","DOI":"10.4049\/jimmunol.178.11.6710","article-title":"Cutting edge: cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease","volume":"178","author":"Frisancho-Kiss","year":"2007","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.clineuro.2024.108183_bib124","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.2174\/156652409789839116","article-title":"Sexual dimorphism in autoimmune disease","volume":"9","author":"McCombe","year":"2009","journal-title":"Curr. Mol. Med"},{"issue":"6","key":"10.1016\/j.clineuro.2024.108183_bib125","first-page":"531","article-title":"Genome-wide gene expression analysis of peripheral leukocytes in relation to the male predominance of Guillain-Barre syndrome: differential gene expression between male and female patients","volume":"126","author":"Yin","year":"2016","journal-title":"Int J. Neurosci."},{"key":"10.1016\/j.clineuro.2024.108183_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1038411","article-title":"Sex differences in Guillain Barr\u00e9 syndrome, chronic inflammatory demyelinating polyradiculoneuropathy and experimental autoimmune neuritis","volume":"13","author":"McCombe","year":"2022","journal-title":"Front Immunol."},{"issue":"12","key":"10.1016\/j.clineuro.2024.108183_bib127","article-title":"Ocular Vascular Events following COVID-19 Vaccines: A Systematic Review","volume":"10","author":"Abu Serhan","year":"2022","journal-title":"Vaccin. [Internet]"},{"key":"10.1016\/j.clineuro.2024.108183_bib128","unstructured":"Data OWi. Share of people with at least one dose of COVID-19 vaccine by age. Our World in Data. 2023."},{"issue":"4","key":"10.1016\/j.clineuro.2024.108183_bib129","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.8879","article-title":"Incidence of Guillain-Barr\u00e9 Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink","volume":"5","author":"Hanson","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"8","key":"10.1016\/j.clineuro.2024.108183_bib130","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain\u2013Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"van den Berg","year":"2014","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2024.108183_bib131","doi-asserted-by":"crossref","first-page":"9913","DOI":"10.1038\/s41598-022-14184-z","article-title":"Old age and multiple comorbidity are associated with delayed diagnosis of Guillain\u2013Barre syndrome","volume":"12","author":"Kim","year":"2022","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.clineuro.2024.108183_bib132","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/jns.12163","article-title":"Guillain-Barr\u00e9 syndrome in the elderly","volume":"21","author":"Peric","year":"2016","journal-title":"J. Peripher Nerv. Syst."},{"issue":"7","key":"10.1016\/j.clineuro.2024.108183_bib133","first-page":"Od01","article-title":"Facial Diplegia with Paresthesia: An Uncommon Variant of Guillain-Barre Syndrome","volume":"10","author":"Kumar","year":"2016","journal-title":"J. Clin. Diagn. Res"},{"issue":"2","key":"10.1016\/j.clineuro.2024.108183_bib134","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ana.26144","article-title":"Guillain-Barr\u00e9 Syndrome Variant Occurring after SARS-CoV-2 Vaccination","volume":"90","author":"Allen","year":"2021","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.clineuro.2024.108183_bib135","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/jnnp-2021-327027","article-title":"Bilateral facial weakness with paraesthesia variant of Guillain-Barr\u00e9 syndrome following Vaxzevria COVID-19 vaccine","volume":"93","author":"Bonifacio","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108183_bib136","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41541-021-00369-6","article-title":"Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action","volume":"6","author":"Heinz","year":"2021","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.clineuro.2024.108183_bib137","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.936896","article-title":"A Clinical Case of COVID-19 Vaccine-Associated Guillain-Barr\u00e9 Syndrome","volume":"23","author":"Hilts","year":"2022","journal-title":"Am. J. Case Rep."},{"issue":"2","key":"10.1016\/j.clineuro.2024.108183_bib138","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s40120-021-00261-4","article-title":"Emerging Infection, Vaccination, and Guillain-Barr\u00e9 Syndrome: A Review","volume":"10","author":"Koike","year":"2021","journal-title":"Neurol. Ther."},{"issue":"5","key":"10.1016\/j.clineuro.2024.108183_bib139","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.neucli.2020.09.007","article-title":"Anti-pan-neurofascin IgM in COVID-19-related Guillain-Barr\u00e9 syndrome: Evidence for a nodo-paranodopathy","volume":"50","author":"Tard","year":"2020","journal-title":"Neurophysiol. Clin."},{"issue":"6","key":"10.1016\/j.clineuro.2024.108183_bib140","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12060711","article-title":"Prognosis of Guillain-Barr\u00e9 Syndrome Linked to COVID-19 Vaccination","volume":"12","author":"Chua","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.clineuro.2024.108183_bib141","unstructured":"E.M.A. COVID-19 Vaccine Janssen: Guillain-Barr\u00e9 syndrome listed as a very rare side effect. European Medicines Agency. 2021."},{"key":"10.1016\/j.clineuro.2024.108183_bib142","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.935275","article-title":"Guillain-Barr\u00e9 Syndrome After Ad26.COV2.S Vaccination","volume":"23","author":"Thant","year":"2022","journal-title":"Am. J. Case Rep."},{"issue":"4","key":"10.1016\/j.clineuro.2024.108183_bib143","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.clineuro.2024.108183_bib144","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91132-3","article-title":"Risk factors for the severity of Guillain-Barr\u00e9 syndrome and predictors of short-term prognosis of severe Guillain-Barr\u00e9 syndrome","volume":"11","author":"Wen","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clineuro.2024.108183_bib145","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-2377-13-95","article-title":"Guillain-Barr\u00e9 syndrome: natural history and prognostic factors: a retrospective review of 106 cases","volume":"13","author":"Gonz\u00e1lez-Su\u00e1rez","year":"2013","journal-title":"BMC Neurol."},{"issue":"5","key":"10.1016\/j.clineuro.2024.108183_bib146","article-title":"Significance of Brighton Criteria in the Early Diagnosis and Management of Guillain-Barr\u00e9 Syndrome","volume":"12","author":"Ghazanfar","year":"2020","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.clineuro.2024.108183_bib147","doi-asserted-by":"crossref","first-page":"Np453","DOI":"10.1177\/0145561320981438","article-title":"Impact of COVID Lockdown on the Presentation of Nasal Foreign Bodies to a Tertiary Care Center","volume":"101","author":"Roy","year":"2022","journal-title":"Ear Nose Throat J."},{"issue":"10","key":"10.1016\/j.clineuro.2024.108183_bib148","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1007\/s00384-020-03635-6","article-title":"The impact of COVID-19 pandemic in the colorectal cancer prevention","volume":"35","author":"Del Vecchio Blanco","year":"2020","journal-title":"Int J. Colorectal Dis."},{"issue":"S1","key":"10.1016\/j.clineuro.2024.108183_bib149","article-title":"Late diagnosis of severe long-standing autoimmune hypothyroidism after the first lockdown for the Covid-19 pandemic: clinical features and follow-up","volume":"92","author":"Mansueto","year":"2022","journal-title":"Acta Biomed."},{"issue":"6","key":"10.1016\/j.clineuro.2024.108183_bib150","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1111\/1462-2920.15549","article-title":"COVID-19: vaccination problems","volume":"23","author":"Br\u00fcssow","year":"2021","journal-title":"Environ. Microbiol"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846724000702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846724000702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:44:26Z","timestamp":1759589066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846724000702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":150,"alternative-id":["S0303846724000702"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2024.108183","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guillain-Barr\u00e9 syndrome after COVID-19 vaccination: A systematic review and analysis of case reports","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2024.108183","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108183"}}